Replies to post #236981 on Biotech Values

[DewDiligence]

GILD 4Q20 HCV sales=$423M, -9% QoQ. This figure consisted of: $229M US; $194M ex-us.

[dewophile]

not sure if you listened to the cc but if so any mention if remdesivir is expected to be effective against new variants ( I would imagine they at least have some in vitro data by now)